United in our mission to improve the lives of patients and their families through innovation
At Neos Therapeutics, our team is dedicated to helping meet the needs of patients who struggle with ADHD and other CNS conditions.
Often, these patients need treatments that have complex medication delivery requirements. We develop, manufacture and commercialize innovative CNS products using our microparticle delivery technology to help meet the needs of these patients.
Our innovative technology enables the development of complex modified-release treatments and is used in our three approved ADHD products, generic tussionex and our growing development pipeline.
Jerry McLaughlin, Chief Executive Officer